Page 8 - 2020 ASCO-GU Canadian Ambassador Program
P. 8
CONTENT – PROSTATE CANCER
TOPICS
Abstract 326: Significant localized reduction in cerebral blood flow (CBF) in regions
relevant to cognitive function with enzalutamide (ENZA) compared to darolutamide (DARO)
and placebo (PBO) in healthy volunteers.
Abstract 93: Oligopelvis-GETUG P07: A multicenter phase II trial of combined salvage
radiotherapy and hormone therapy in oligorecurrent pelvic node relapses of prostate
cancer.
